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Abstract
Background—The extent to which relative contributions of traditional cardiovascular factors
risk to incident cardiovascular disease (CVD) may have changed over time remains unclear.
Methods and Results—We studied 13,541 participants (56% women, 26% black) in the
Atherosclerosis Risk in Communities Study, aged 52-66 years and free of CVD at exams in
1987-89, 1990-92, 1993-95, or 1996-98. At each exam, we estimated the population attributable
risks (PAR) of traditional risk factors (hypertension, diabetes, obesity, hypercholesterolemia, and
smoking) for the 10-year incidence of CVD. Overall, the PAR of all risk factors combined
appeared to decrease from 1987-89 to 1996-98 (0.58 to 0.53). The combined PAR was higher in
women than men in 1987-89 (0.68 vs. 0.51, P<0.001) but not by 1996-98 (0.58 vs. 0.48, P=0.08).
The combined PAR was higher in blacks than whites in 1987-89 (0.67 vs. 0.57, P=0.049), and this
difference was more pronounced by 1996-98 (0.67 vs. 0.48, P=0.002). By 1996-98, the PAR of
hypertension had become higher in women than men (P=0.02) and also appeared higher in blacks
than whites (P=0.08). By 1996-98, the PAR of diabetes remained higher in women than men
(P<0.0001) and in blacks than whites (P<0.0001).
Correspondence: Susan Cheng, MDBrigham and Women's Hospital, Cardiovascular Division, 75 Francis Street, Boston, MA
02115Phone: 857-307-1988Fax: 857-307-1944 scheng3@partners.org.
Conflict of Interest Disclosures: None.
NIH Public Access
Author Manuscript
Circulation. Author manuscript; available in PMC 2015 September 02.
Published in final edited form as:






















Conclusions—The contribution to CVD of all traditional risk factors combined is greater in
blacks than whites, and this difference may be increasing. The contributions of hypertension and
diabetes remain especially high, in women as well as blacks. These findings underscore the
continued need for individual as well as population approaches to CVD risk factor modification.
Keywords
cardiovascular disease risk factors; cardiovascular disease prevention; gender differences; race and
ethnicity
INTRODUCTION
Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality in the
United States, with an overall economic burden in excess of $440 billion annually.1,2 Data
from prior studies suggest that the incidence of CVD has been decreasing over time,3-7 in
association with increasing public health emphasis on the prevention and treatment of
modifiable risk factors such as hypertension and hypercholesterolemia.8-13 However, several
studies indicate that improvements in CVD incidence are lagging in certain subgroups,
including women and blacks.3-6 The degree to which these trends may be due to differences
between subgroups in the relative contribution of traditional risk factors to incident CVD is
not known. To better understand changes over time in the contribution of risk factors to
incident CVD in the population at large, as well as in important subgroups, we examined the
proportion of CVD risk attributable to traditional risk factors in a large bi-racial sample of
men and women living in the community with longitudinal data available and outcomes
surveillance spanning over 2 decades.
METHODS
Study Sample
The study design and sampling of the Atherosclerosis Risk in Communities (ARIC) Study
has been described (Supplement).14 Of all 15,792 participants who were enrolled in ARIC
at the first exam, a total of 13,541 participants (56% women, 26% black) contributed any
person observations for the current analyses. Specifically, a total of 8,240 participants had
no known CVD (coronary heart disease, heart failure, or prior cerebrovascular event), had
no missing data on traditional cardiovascular risk factors (i.e. obesity, hypertension,
diabetes, hypercholesterolemia, and smoking status), and were aged 52 to 66 years at exam 1
(1987-1989). The number of participants from the study sample who, due to aging, were
similarly 52 to 66 years and free of CVD at the subsequent exams was 8915 (exam 2,
1990-1992), 8467 (exam 3, 1993-1995), and 6884 (exam 4, 1996-1998). Institutional review
boards approved the original study protocol at each ARIC site. Participants all provided
written informed consent and study procedures were in accordance with institutional
guidelines regarding the protection of human subjects.
Clinical Assessment
We used data collected from each exam to define presence of the following traditional risk
factors: obesity (body mass index ≥30 kg/m2), hypertension (systolic blood pressure ≥140
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mmHg or diastolic blood pressure ≥90 mmHg or taking anti-hypertensive medication),
hypercholesterolemia (total cholesterol ≥200 mg/dL or taking cholesterol lowering
medication), diabetes (fasting glucose ≥126 mg/dL, non-fasting glucose ≥200 mg/dL, or
report of clinical diagnosis or treatment of diabetes), and current smoking status (self-
reported active smoking within 1 year prior to the exam). Individuals identified as having
hypertension or diabetes at a given exam were considered as having hypertension or
diabetes, respectively, at all subsequent exams. Otherwise, individuals with missing
covariate data at a subsequent exam were coded as missing that variable for that particular
exam. All participants were followed through December 31, 2008 for the incidence of
cardiovascular events (coronary heart disease, heart failure, stroke) or CVD death,
ascertained according to previously-defined criteria (Supplement).
Statistical Analyses
At each of the exams 1 through 4 (i.e. the ‘baseline’ exams), we estimated the population
attributable risk (PAR) % of each primary risk exposure (obesity, hypertension, diabetes,
hypercholesterolemia, and smoking status) for the 10-year incidence of CVD using a method
that is considered internally valid when adjusted relative risks must be used to account for
possible confounding (Supplement).15 We performed all PAR calculations using the risk
factor prevalence at each exam and the multivariable-adjusted hazards ratio estimate for 10
years after each exam, derived from Cox proportional hazards models adjusting for all
primary risk factors. All Cox models were also stratified by sex, race, study center, and age
(i.e. controlled for these 4 variables without requiring the standard proportional hazards
assumption). We performed all analyses using STATA version 12.1 (College Station, TX),
with a 2-tailed P value <0.05 considered statistically significant.
RESULTS
The sample characteristics are shown in Table 1 and Supplemental Table 1. Of the
participants who contributed observations to this analysis, 56% were women and 26% were
black. Mean body mass index slightly but significantly increased from 1987-1989 through
1996-1998 (P<0.001), and the proportion of individuals with obesity increased from 26% to
33% over this same time period (P<0.001). The frequencies of hypertension (39% to 45%)
and diabetes (12% to 14%) also increased from 1987-1989 to 1996-1998, whereas the
frequencies of smoking (24% to 16%) and hypercholesterolemia (68% to 55%) decreased
(P<0.001 for all).
The 10-year crude CVD event rate was 1.51 (95% CI 1.43-1.60) per 100 person-years for
middle-aged participants (52-66 years old) who attended the first exam in 1987-1989, with
similar rates observed for those attending exams in 1990-1992 (1.59 [1.51-1.68]), 1993-1995
(1.52 [1.44-1.61], and 1996-1998 (1.45 [1.36-1.55]). For participants attending the initial
1987-1989 exam, crude 10-year event rates were higher with increasing number of CVD
risk factors present: 0.8, 0.9, 1.6, 2.5, 4.4, and 7.5 per 100 person-years for individuals with
0 to 5 risk factors, respectively; this trend was similar across time (Supplemental Table 2).
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Temporal Trends in the Total Sample
Overall, the single largest and most consistent contributor to population CVD risk over time
was hypertension (Table 2); the population risk attributable to hypertension was not
significantly different in 1987-1989 compared with 1996-1998 (PAR 0.25 vs. 0.25, P=0.82).
Hypercholesterolemia was a major contributor to CVD risk in 1987-1989, but this
contribution appeared to have decreased by 1996-1998 (PAR 0.18 vs. 0.09, P=0.08) in the
setting of both lower prevalence and lower associated hazard by exam 4 (Table 2). Although
the prevalence of smoking decreased over time, this was accompanied by an associated
hazard that remained high; thus, the overall population attributable risk for smoking did not
significantly decrease from 1987-1989 to 1996-1998 (PAR 0.15 vs. 0.13, P=0.16). The CVD
risks attributable to diabetes (PAR 0.15 vs 0.17, P=0.17) and obesity (PAR 0.06 vs. 0.06,
P=0.83) also remained similar from 1987-1989 through 1996-1998. In the total study
sample, well over 50% of the CVD events in the population was explained by all the risk
factors combined. The PAR for all 5 major risk factors appeared higher in 1987-1989 (PAR
0.58 [95% CI 0.53, 0.62]) than in 1996-1998 (PAR 0.53 [95% CI 0.47, 0.58]) although this
difference in PARs was not statistically significant (P=0.13).
Temporal Trends by Sex
Sex-based variation in estimated attributable risks for CVD existed initially in 1987-1989 as
well as subsequent time points (Table 3 and Figure 1). In analyses stratified by sex
(Supplemental Figure 1), the attributable contribution of all 5 risk factors combined was
significantly higher in women than in men in 1987-1989 (PAR 0.68 [0.62, 0.74] vs. 0.51
[0.44, 0.57], P<0.001) but not by 1996-1998 (PAR 0.58 [0.49, 0.65] vs. 0.48 [0.41, 0.55],
P=0.08). The extent to which hypertension was a greater CVD risk contributor in women
compared with men was more evident later in 1996-1998 (PAR 0.32 vs 0.19, P=0.02) than
earlier in 1987-1989 (PAR 0.28 vs 0.23, P=0.23) (Supplemental Figure 2). Diabetes was a
greater contributor to CVD risk in women compared with men, and this trend remained
constant over time: PAR 0.22 vs. 0.11 (P<0.001) in 1987-1989, and PAR 0.21 vs. 0.14
(P<0.001) in 1996-1998. Smoking was a greater contributor to CVD risk in women
compared to men early on in 1987-1989 (PAR 0.22 vs 0.10, P<0.001) and this gender gap
narrowed by 1996-1998 (PAR 0.14 vs. 0.11, P=0.07). Similarly, obesity was a more
important contributor to CVD risk in women than men earlier on in 1987-1989 (PAR 0.13
vs. 0.03, P=0.016) but not later on by 1996-1998 (PAR 0.08 vs. 0.04, P=0.54). Although
more prevalent in women than men, the contribution of hypercholesterolemia to CVD risk
was similar between the women and men at all exams. Except for obesity, the reason women
often had higher PARs than men was because the HRs for CVD tended to be greater for risk
factors, rather than the prevalence of risk factors (Supplemental Figure 2).
Temporal Trends by Race
There were marked differences in the attributable risks for CVD between blacks and whites
(Table 4 and Figure 1). As show in Supplemental Figure 1, the contribution of all risk
factors combined was higher in blacks than whites in 1987-1989 (PAR 0.67 [0.57, 0.74] vs.
0.56 [0.50, 0.61], P=0.049) and this difference was more pronounced by 1996-1998 (PAR
0.67 [0.57, 0.75] vs. 0.48 [0.41, 0.54], P=0.002). For the most part, blacks compared with
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whites had higher prevalences of risk factors but not greatly different associated hazards.
The extent to which hypertension was a greater CVD risk contributor in blacks compared
with whites was more apparent in 1987-1989 (PAR 0.40 vs. 0.21, P=0.002) than in
1996-1998 (PAR 0.36 vs. 0.21, P=0.08) (Supplemental Figure 3). However, diabetes
remained a significantly greater contributor to CVD risk in blacks than whites over time,
with PARs of 0.22 vs. 0.13 (P<0.001) in 1987-1989 and PARs of 0.28 vs. 0.13 (P<0.001) in
1996-1998. Even further, the contribution of diabetes to CVD risk increased in blacks (PAR
0.22 vs. 0.28, P=0.03) but stayed constant in whites (PAR 0.13 vs. 0.13, P=0.80) over the
time period from 1987-1989 to 1996-1998; this increase in diabetes-related CVD risk was
driven by both increasing prevalence as well as increasing associated hazards (Table 4 and
Supplemental Figure 3). Hypercholesterolemia conferred similar risks in whites and
blacks, although this contribution decreased over time in whites (PAR 0.22 vs. 0.10,
P=0.04). Although more prevalent in blacks than whites, contributions of obesity and
smoking to CVD risk were not significantly different between races at all time points.
In secondary analyses conducted using a hard CHD endpoint (defined as including only
hospitalized myocardial infarction or CHD death) as part of the composite CVD outcome,
we observed results that were similar to those of the main analyses. These results were
similar for the total sample as well as by sex and race (data not shown). In analyses repeated
separately for each study center, we observed geographic variation that was not completely
reflected by between-center differences in racial distributions (Supplemental Table 3).
DISCUSSION
We investigated temporal trends in contributions of risk factors to CVD in a large multi-
center and bi-racial community-based cohort, with clinical assessments conducted over 12
years and outcomes surveillance spanning over 2 decades. We observed a trend of
decreasing overall population risk attributable to traditional risk factors over time, largely
due to the decreasing prevalence of hypercholesterolemia and smoking. However, the
combined contribution of all traditional risk factors has remained substantially higher in
women compared with men, and in blacks compared with whites. These sex- and race-based
differences remain especially pronounced for hypertension and diabetes. Together, these
data highlight the continued need for targeted risk factor modification despite recent
improvements in the public health efforts to reduce the overall burden of CVD risk.
In our total study sample, the CVD risk attributable to all the 5 major traditional risk factors
that we analyzed steadily decreased over the time period extending from the late 1980s
through the last decade. These overall trends may be related to concomitant changes in the
definitions of select CVD risk factors, and their effects on practice in the community,16
along with increasing rates of treatment and control for select risk factors.17 Specifically, we
observed marked declines in the prevalence of hypercholesterolemia and particularly
smoking, which have been reported previously.17 Interestingly, the hazard associated with
hypercholesterolemia also decreased, whereas the hazard associated with smoking actually
increased over time. The trends observed for hypercholesterolemia may well have been
related to substantially increased use of cholesterol-lowering medication over time in the
population at large; further research is warranted to better understand time trends of the
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population risk attributable to statin use as well as other medications used to modify
cardiovascular risk. These observations may also be related to birth cohort effects or
differing dose-response relationships (not captured by the binary variables we studied) in the
magnitude of CVD risk associated with having persistently high cholesterol or being an
active smoker. Accordingly, with respect to hypertension, secular trends and improvements
in blood pressure control are a likely explanation for the finding that the hazard associated
with hypertension decreased even though hypertension prevalence increased over time.8,18
Although it is well known that the prevalence of obesity is increasing nationwide,19,20 we
observed that the CVD risk attributable to obesity has remained relatively low as well as
constant over time. It is possible that obesity may have longer term effects than could be
seen within 10 years of follow up,21 and that such longer term effects may well manifest as
risk attributable to diabetes. Indeed, consistent with national and worldwide trends,22 the
overall prevalence of diabetes increased over the study period; this increase was associated
with hazards for CVD that remained high overall, with some notable variations by subgroup.
We observed substantial differences between women and men in population attributable
risks for CVD over time. At exam 1, the proportion of CVD risk attributable to all risk
factors was significantly higher in women than men. Prior studies that have noted similar
sexual dimorphism in attributable CVD risks associated with major risk factors such as
hypertension and diabetes.23-25 These sex-based differences may be related to the possibility
that nontraditional risk factors contribute more to CVD in risk in men than women, or that
women were historically less likely to have prevalent risk factors controlled.26,27 We
observed that the overall sex difference in PARs had substantially narrowed by 1996-1998,
potentially related to the success of public health effects aimed at increasing the awareness
of CVD risk in women.28 Indeed, prevalence of hypertension was higher in women than
men in 1987-1989, and this difference decreased over time. However, women still tended to
have more prevalent hypertension as well as a higher associated CVD risk, even by
1996-1998; this finding could be related to the greater proportion of isolated systolic
hypertension and arterial stiffness in women than men.29-31 Despite similar trends to men in
the decreasing prevalence of smoking and increasing prevalence of obesity, women tended
to display consistently higher hazards of CVD risk associated with both of these risk factors
over time. Most importantly, the CVD risk attributable to diabetes remained significantly
higher in women than men over time, driven by higher associated hazards despite lower
prevalence rates. Prior studies have reported similar sex-based differences in the risks
associated with smoking,32 obesity,33 and diabetes34-36 although without specifically
temporal trends in both prevalence and associated hazards in the context of other risk
factors. The reasons for persistent sex differences in attributable CVD risks over time are not
yet clear,37 and could be related to greater clustering of risk factors in women than men,38,39
continued under-recognition or under-treatment of prevalent risk factors in women,28 or
hormonal or non-hormonal biological variation that has yet to identified.40 Additionally,
men could have more inherent unexplained risk, which could be accounted for by non-
traditional risk factors.
We also observed marked differences between blacks and whites in the temporal trends of
population attributable risks for CVD. The risk attributable to all 5 traditional risk factors
combined was higher in blacks than whites in 1987-1989 and this difference was even larger
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by 1996-1998, indicating that efforts to improve CVD risk factor modification are not
benefitting blacks as much as whites. The two primary contributors to race-based differences
in CVD risk over time were hypertension and diabetes. The prevalence of hypertension
increased in both blacks and whites, but both prevalence rates and associated hazards were
consistently higher in blacks than whites at all exams. Race differences for diabetes were
even more profound. In whites, the prevalence of diabetes remained constant while the
associated hazard tended to decrease over time; in blacks, the prevalence of diabetes was
consistently over double that in whites and the diabetes-associated hazards actually
increased over time in blacks. Consequently, the attributable CVD risk of diabetes was
significantly higher in 1996-1998 than 1987-1989 in blacks. Although numerous prior
studies have reported differences by race in the prevalence of CVD risk factors including
hypertension and diabetes,41 fewer have investigated race differences in associated
hazards,42-44 and none have previously examined race variation in both prevalence and
hazards over time. Prior work in the ARIC cohort has noted that the proportion of CVD risk
explained by traditional risk factors is much larger in blacks compared to whites,
particularly when considering borderline risk factors;45 therefore, race-based differences
over time may be even more pronounced when accounting for borderline clinical risk
factors. Because the vast majority of blacks in this study were enrolled at the Jackson study
center, it is important to note that our race-based analyses may have been particularly
influenced by geography even in analyses stratified by study center. Notwithstanding the
multiple additional socio-economic, clinical, and biological factors that may be
implicated,44 our results highlight the magnitude and trajectory of differences between
blacks and whites in the contribution of risk factors to CVD.
Several limitations of the study merit consideration. Our composite CVD outcome included
coronary revascularization events; although these procedures may have been performed less
frequently in certain subgroups, the main study findings were similar for subgroups when
analyses were repeated using the CVD outcome that did not include coronary
revascularization. It is known that precision in the estimate of the PAR is suboptimal for
highly prevalent exposures;15 thus, PAR estimates for very prevalent exposures within a
given sample or subgroup should be interpreted with caution. Because PAR estimates can be
calculated only for binary variables, we were not able to analyze continuous variables that
may contribute residual CVD risk but are without widely established definitions of normal
versus abnormal; thus, we focused on presence versus absence of traditional risk factors that
are easily assessed and are also generally considered to be modifiable. Because we used
conventional definitions for binary risk factor variables, PARs reported herein are lower
than estimates that could be calculated using risk factor definitions based on “ideal”
thresholds.12 It is important to note that the PAR estimate provides a comparison between
the observed data and a hypothetical scenario where a given risk factor has been eliminated;
despite the impracticality of such an assumption, PAR estimates can provide a common
scale for comparing the potential population-level impact of targeting interventions for
preventing or treating a given risk factor. Although the time period studied was relatively
short, it included an interval that captured major changes in risk factors. Indeed, the
observed time trends are likely related to a combination of effects from aging, birth cohort
differences, and secular changes that cannot be completely measured and accounted for in
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our models. In addition, sampling at the more recent exams may yet have been influenced by
survivor bias. To facilitate comparisons across time intervals, we restricted analyses to a
sample that was middle-aged as well as predominantly either white or black with respect to
racial/ethnic group. Generalizability of our findings to other age and racial/ethnic groups or
to populations beyond the 4 ARIC communities is unknown.
We examined the temporal trends in the attributable contributions of traditional risk factors
to incident CVD in a large community-based cohort comprising middle-aged men and
women, representing both blacks and whites. The overall PAR for all risk factors remains
well over 50%, indicating that preventing or removing these risk factors might eliminate a
large proportion of CVD in the community. In fact, if the whole population could maintain
low risk status through primordial prevention, most CVD events might be
prevented.12,20,46,47 Indeed, we observed that the overall 10-year rate of CVD in a middle-
aged sample is ~1.5 per 100 person-years and among those with no major risk factors, the
CVD rate is only ~0.7. In addition to persistently high PAR for the total sample, we
observed that the contribution to incident CVD of all traditional risk factors combined is
greater in blacks than whites, and this difference may be increasing with time. The risks
attributable to hypertension and diabetes remain especially high, in women as well as blacks.
Together, these findings underscore the continued need for individual as well as population
approaches to CVD risk factor modification.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Population attributable risks by sex and race. The population attributable risk (PAR) of
major risk factors for the 10-year incidence of cardiovascular disease is shown by sex and
race for each of the 4 baseline exams. Units of PAR are shown on the logarithmic scale to
allow for comparisons within and across exams.
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Table 1
Characteristics of the Baseline Sample (Aged 52-66 years) at Each Exam
Characteristic Exam 1 1987-1989 Exam 2 1990-1992 Exam 3 1993-1995 Exam 4 1996-1998
No. participants 8214 8956 8514 6872
Age, years 58±4 59±4 59±4 60±4
Women, % 54 56 58 59
Black, % 23 23 23 23
Body mass index, kg/m2 27.4±5.1 27.8±5.2 28.4±5.4 28.9±5.6
Systolic blood pressure, mm Hg 124±19 122±19 123±18 125±18
Diastolic blood pressure, mmHg 73±11 72±10 72±10 72±10
Hypertension medication use, % 29 29 31 35
Cholesterol-lowering medication use, % 3 6 8 10
Obesity, % 26 27 33 36
Current smoker, % 24 21 18 16
Hypertension, % 39 38 40 45
Hypercholesterolemia, % 68 61 59 55
Diabetes, % 12 14 13 14
Values are displayed as means±standard deviation or percent frequencies.
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Table 2
Temporal Trends in Population Attributable Risk in the Total Sample
*
Risk Factor Prevalence, % (95% CI) Adjusted HR (95% CI) Adjusted PAR (95% CI)
Hypertension
    Exam 1 39 (38, 41) 1.82 (1.61, 2.07) 0.25 (0.21, 0.29)
    Exam 2 38 (37, 39) 1.89 (1.68, 2.12) 0.26 (0.23, 0.29)
    Exam 3 40 (39, 41) 1.64 (1.45, 1.86) 0.22 (0.17, 0.26)
    Exam 4 45 (43, 46) 1.68 (1.46, 1.94) 0.25 (0.19, 0.29)
        P value – – 0.82
Diabetes
    Exam 1 12 (11, 12) 2.45 (2.12, 2.83) 0.15 (0.13, 0.16)
    Exam 2 14 (13, 15) 2.15 (1.89, 2.45) 0.15 (0.13, 0.17)
    Exam 3 13 (13, 14) 2.52 (2.20, 2.89) 0.17 (0.16, 0.19)
    Exam 4 14 (13, 15) 2.44 (2.09, 2.85) 0.17 (0.15, 0.19)
        P value – – 0.17
Obesity
    Exam 1 26 (25, 27) 1.24 (1.08, 1.41) 0.06 (0.03, 0.10)
    Exam 2 27 (27, 28) 1.17 (1.04, 1.33) 0.05 (0.01, 0.09)
    Exam 3 33 (32, 34) 1.20 (1.06, 1.37) 0.06 (0.02, 0.11)
    Exam 4 36 (35, 37) 1.15 (1.00, 1.33) 0.06 (0.00, 0.11)
        P value – – 0.83
Hypercholesterolemia
    Exam 1 68 (67, 69) 1.34 (1.18, 1.53) 0.18 (0.11, 0.25)
    Exam 2 61 (60, 62) 1.26 (1.12, 1.42) 0.13 (0.07, 0.19)
    Exam 3 59 (58, 60) 1.34 (1.18, 1.51) 0.16 (0.10, 0.22)
    Exam 4 55 (54, 57) 1.20 (1.04, 1.37) 0.09 (0.03, 0.16)
        P value – – 0.08
Smoking
    Exam 1 24 (23, 25) 1.84 (1.62, 2.10) 0.15 (0.12, 0.17)
    Exam 2 21 (21, 22) 1.83 (1.61, 2.07) 0.13 (0.11, 0.15)
    Exam 3 18 (17, 19) 2.23 (1.95, 2.54) 0.16 (0.14, 0.17)
    Exam 4 16 (15, 17) 2.07 (1.77, 2.43) 0.13 (0.11, 0.14)
        P value – – 0.16
All results shown are from stratified Cox models, with age, sex, race, and study center as stratification factors. All analyses are adjusted for age,
hypertension, diabetes, obesity, hypercholesterolemia, and smoking.
*
Numbers of CVD cases per total individuals at risk (i.e. sample sizes) were as follows: 1136 of 8214 at Exam 1, 1293 of 8956 at Exam 2, 1178 of
8514 at Exam3, and 908 of 6872 at Exam 4. P values are for comparisons of estimates between Exam 1 and Exam 4.
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